<DOC>
	<DOCNO>NCT00444158</DOCNO>
	<brief_summary>MOA-728 , investigational drug , currently study relief constipation associate postoperative ileus treatment opioid induced constipation patient receive palliative care . This study investigate IV formulation MOA-728 compare PK/PD time point 20-minute versus 4-hour infusion .</brief_summary>
	<brief_title>Double-Blind , Double-Dummy , 2-Period Crossover 20-Minute Versus 4-hour IV MOA-728 Stable Methadone Subjects</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Generally healthy men nonlactating , nonpregnant woman age 18 65 year BMI 18.0 35.0 kg/m2 Must receive methadone treatment great equal 30 mg/day least one month positive drug screen methadone High probability compliance completion study Significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease . Presence history disorder may prevent successful completion study . Any surgical medical condition interfere distribution , metabolism excretion test article . Acute disease state , family history long QT syndrome and/or sudden cardiac death , allergy opioids drug . Use investigational prescription drug within 30 day , OTC drug include herbal supplement within 14 day drug require maintain regulation bowel movement 48 hour study day 1 . History alcoholism within 1 month study day 1 , admit alcohol abuse , consumption 2 standard unit alcohol per day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>opioids</keyword>
	<keyword>chronic pain</keyword>
</DOC>